Ice skating for the Daniel den Hoed Fund

Schaatsbaan Rotterdam opens its doors from 28 November to 26 February '21 for the eighth time in a row. This year the Daniel den Hoed Fund is again the charity of the skating rink. When buying a ticket, skaters can choose to support scientific cancer research at Erasmus MC.

Skating for Daniel

When buying a ticket the skater gets the option to give an extra contribution to the charity. This extra contribution makes scientific cancer research at Erasmus MC possible. Shakira Sohier-Borst, director Daniel den Hoed Fund: 'We are glad that we are once again the good cause of Schaatsbaan Rotterdam. This year we are supporting groundbreaking research into the role of lymph nodes in the success of immunotherapy'.

Tijs Nederlof, director of Schaatsbaan Rotterdam: 'We are happy to contribute in this way. That's why this year we're helping the Daniel den Hoed Fund to raise money for scientific cancer research at Erasmus MC. Especially in these uncertain times, when all attention is naturally focused on the development of a vaccine against Covid-19 and on research into the developments and consequences of the coronavirus, it is important not to forget scientific cancer research'.

Tickets can be bought at More information about the research can be found at:

Corona Protocol

This winter skating rink Rotterdam follows the corona guidelines of the RIVM and the NOC*NSF for a safe sports environment. Therefore, this year it is only possible to buy a ticket online and reserve a time slot of one hour. A limited number of people can use the skating rink per hour. You can read more information on

About Erasmus MC

Erasmus MC is the largest University Medical Centre in the Netherlands. It is committed to a healthy population. More than 14,000 employees dedicate themselves daily to excellent care through internationally groundbreaking research and education. They increase knowledge about illness and health and link the latest scientific insights with practical and preventative action, so that patients benefit optimally and healthy people can remain healthy. Being visibly better and remaining at the forefront of complex, innovative and acute care through collaboration with others are important ambitions of Erasmus MC.

Published on 1 dec 2020

Read all the news

More news